Last updated on February 2020

Evaluate Efficacy & Safety of Eptinezumab Administered Intravenously in Subjects Experiencing Acute Attack of Migraine


Brief description of study

This will be a parallel group, double-blind, randomized, placebo-controlled study assessing the efficacy of eptinezumab for acute migraine, defined as an active intercurrent migraine occurring in those patients who are candidates for preventive therapy. Subjects will be randomized to receive a single dose of eptinezumab or placebo in a 1:1 ratio. The total study duration will be approximately 4 to 12 weeks, including up to an 8-week screening period, with clinic visits occurring on Screening, Day 0 (dosing day), and Week 4.

Detailed Study Description

The purpose of this study is to evaluate the efficacy and safety of eptinezumab administered intravenously in subjects experiencing an acute attack of migraine.

Clinical Study Identifier: NCT04152083

Find a site near you

Start Over

Texas Center for Drug Development Inc

Houston, TX United States
7.65miles
  Connect »

Ventavia Research Group, LLC

Fort Worth, TX United States
234.98miles
  Connect »

Ventavia Research Group, LLC

Keller, TX United States
245.31miles
  Connect »

Headache Neurology Research Institute

Ridgeland, MS United States
360.53miles
  Connect »

Baptist Health Center for Clinical Research

Little Rock, AR United States
387.4miles
  Connect »

Alabama Clinical Therapeutics

Birmingham, AL United States
577.97miles
  Connect »

College Park Family Care Center Physicians

Overland Park, KS United States
636.61miles
  Connect »

Chattanooga Medical research LLC

Chattanooga, TN United States
691.98miles
  Connect »

WR-ClinSearch LLC

Chattanooga, TN United States
698.06miles
  Connect »

iResearch Atlanta, LLC

Decatur, GA United States
706.58miles
  Connect »

Clinical Research of Central Florida

Winter Haven, FL United States
831.85miles
  Connect »

Central Kentucky Research Associates

Lexington, KY United States
846.67miles
  Connect »

Meridien Research - Maitland

Maitland, FL United States
847.86miles
  Connect »

CTI Clinical Research center

Cincinnati, OH United States
898.06miles
  Connect »

Research Site

Chicago, IL United States
940.8miles
  Connect »

MedVadis Research Corporation, LLC

Chicago, IL United States
940.8miles
  Connect »

AGA Clinical trials

Hialeah, FL United States
958.24miles
  Connect »

Arizona Research Center

Phoenix, AZ United States
1019.7miles
  Connect »

Neuroscience Group

Neenah, WI United States
1065.51miles
  Connect »

Michigan Head Pain and Neurological institute

Ann Arbor, MI United States
1079.55miles
  Connect »

Neuro-Behavioral Clinical Research Inc

North Canton, OH United States
1094.81miles
  Connect »

Frontier Clinical Rsearch LLC

Smithfield, PA United States
1119.6miles
  Connect »

Research Site

Salt Lake City, UT United States
1193.54miles
  Connect »

J. Lewis Research, Inc. / Foothill Family Clinic

Salt Lake City, UT United States
1193.54miles
  Connect »

Nevada Headache Institute

Las Vegas, NV United States
1230.54miles
  Connect »

Dent Neurologic Institute - Amherst

Amherst, NY United States
1293.03miles
  Connect »

Excell research Inc

Oceanside, CA United States
1310.36miles
  Connect »

North County Neurology Associates

Carlsbad, CA United States
1310.53miles
  Connect »

Coastal Connecticut Research LLC

New London, CT United States
1526.29miles
  Connect »

MedVadis Research Corporation, LLC

Waltham, MA United States
1595.76miles
  Connect »

Research Site

Watertown, MA United States
1598.32miles
  Connect »

Research Site

Bellevue, WA United States
1882.13miles
  Connect »

Ltd "Aversi Clinic"

Tbilisi, Georgia
6884.77miles
  Connect »